95 related articles for article (PubMed ID: 33086170)
1. Artesunate inhibits Sjögren's syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling.
Zhan T; Wang B; Fu J; Shao Y; Ye L; Shi H; Zheng L
Phytomedicine; 2021 Jan; 80():153381. PubMed ID: 33086170
[TBL] [Abstract][Full Text] [Related]
2. Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren's syndrome.
Thompson N; Isenberg DA; Jury EC; Ciurtin C
Rheumatology (Oxford); 2016 Sep; 55(9):1548-55. PubMed ID: 26790457
[TBL] [Abstract][Full Text] [Related]
3. Implications of IFNγ SNP rs2069705 in primary Sjögren's syndrome: transcriptional activation and B cell infiltration.
Chen X; Li M; Li H; Liu M; Su J; Ji Y
Am J Physiol Cell Physiol; 2024 May; 326(5):C1494-C1504. PubMed ID: 38406824
[TBL] [Abstract][Full Text] [Related]
4. Rutin alleviates Sjogren's syndrome via CaR/NLRP3/NF-κB signal pathway.
He J; Xu M; Wu S
In Vitro Cell Dev Biol Anim; 2024 Apr; 60(4):411-419. PubMed ID: 38587579
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of CD4 + T cells by fanchinoline via miR506-3p/NFATc1 in Sjögren's syndrome.
Shao Y; Fu J; Zhan T; Yin J; Xu J; Lu Y; Luo Q; Yu C
Inflammopharmacology; 2023 Oct; 31(5):2431-2443. PubMed ID: 37450074
[TBL] [Abstract][Full Text] [Related]
6. Toll-Like Receptor 7 Is Required for Lacrimal Gland Autoimmunity and Type 1 Diabetes Development in Male Nonobese Diabetic Mice.
Debreceni IL; Chimenti MS; Serreze DV; Geurts AM; Chen YG; Lieberman SM
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322152
[TBL] [Abstract][Full Text] [Related]
7. Blocking IAg
Gupta S; Li D; Ostrov DA; Nguyen CQ
Life Sci; 2022 Jan; 288():120182. PubMed ID: 34843735
[TBL] [Abstract][Full Text] [Related]
8. Fingolimod reduces salivary infiltrates and increases salivary secretion in a murine Sjögren's model.
Cohen PL; McCulloch A
J Autoimmun; 2020 Dec; 115():102549. PubMed ID: 33059968
[TBL] [Abstract][Full Text] [Related]
9. PANoptosis Features, a Humanized NSG Murine Model of Sjogren's Syndrome.
Yang Y; Zhang H; Xiao X; Guo M
DNA Cell Biol; 2024 May; 43(5):207-218. PubMed ID: 38635961
[TBL] [Abstract][Full Text] [Related]
10. Advances in Pathogenesis of Sjögren's Syndrome.
Tian Y; Yang H; Liu N; Li Y; Chen J
J Immunol Res; 2021; 2021():5928232. PubMed ID: 34660815
[TBL] [Abstract][Full Text] [Related]
11. Central role for marginal zone B cells in an animal model of Sjogren's syndrome.
Shen L; Gao C; Suresh L; Xian Z; Song N; Chaves LD; Yu M; Ambrus JL
Clin Immunol; 2016 Jul; 168():30-36. PubMed ID: 27140729
[TBL] [Abstract][Full Text] [Related]
12. Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome.
Shim GJ; Warner M; Kim HJ; Andersson S; Liu L; Ekman J; Imamov O; Jones ME; Simpson ER; Gustafsson JA
Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12628-33. PubMed ID: 15314222
[TBL] [Abstract][Full Text] [Related]
13. Melatonin improves salivary gland damage and hypofunction in pSS by inhibiting IL-6/STAT3 signaling through its receptor-dependent manner.
Liu Y; Wang F; Cheng B; Zhou G
Mol Immunol; 2024 May; 169():10-27. PubMed ID: 38460474
[TBL] [Abstract][Full Text] [Related]
14. Extracellular vesicles of iPS cells highly capable of producing HGF and TGF-β1 can attenuate Sjögren's syndrome via innate immunity regulation.
Ogata K; Moriyama M; Kawado T; Yoshioka H; Yano A; Matsumura-Kawashima M; Nakamura S; Kawano S
Cell Signal; 2024 Jan; 113():110980. PubMed ID: 37981065
[TBL] [Abstract][Full Text] [Related]
15. Impaired B Cell Apoptosis Results in Autoimmunity That Is Alleviated by Ablation of Btk.
Wright JA; Bazile C; Clark ES; Carlesso G; Boucher J; Kleiman E; Mahmoud T; Cheng LI; López-Rodríguez DM; Satterthwaite AB; Altman NH; Greidinger EL; Khan WN
Front Immunol; 2021; 12():705307. PubMed ID: 34512628
[TBL] [Abstract][Full Text] [Related]
16. Ectopic lymphoid neogenesis and lymphoid chemokines in Sjogren's syndrome: at the interplay between chronic inflammation, autoimmunity and lymphomagenesis.
Bombardieri M; Pitzalis C
Curr Pharm Biotechnol; 2012 Aug; 13(10):1989-96. PubMed ID: 22208651
[TBL] [Abstract][Full Text] [Related]
17. PRMT5 participates in B cell overactivation in patients with primary Sjogren's syndrome (pSS) through RSAD2-mediated NF-κB signaling.
Zhu H; Zheng J; Zhou Y; Wu T; Zhu T
Immun Inflamm Dis; 2023 Dec; 11(12):e1102. PubMed ID: 38156384
[TBL] [Abstract][Full Text] [Related]
18. Carbon quantum dots as immune modulatory therapy in a Sjögren's syndrome mouse model.
Fu C; Qin X; Shao W; Zhang J; Zhang T; Yang J; Ding C; Song Y; Ge X; Wu G; Bikker FJ; Jiang N
Oral Dis; 2024 Apr; 30(3):1183-1197. PubMed ID: 37125663
[TBL] [Abstract][Full Text] [Related]
19. Predictive modeling of aspirin-triggered resolvin D1 pharmacokinetics for the study of Sjögren's syndrome.
Yellepeddi VK; Baker OJ
Clin Exp Dent Res; 2020 Apr; 6(2):225-235. PubMed ID: 32250566
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory Effects of Extracellular Vesicles from iPS-Cell-Derived Mesenchymal Stem Cells on the Onset of Sialadenitis in Sjögren's Syndrome Are Mediated by Immunomodulatory Splenocytes and Improved by Inhibiting miR-125b.
Zhao Q; Bae EH; Zhang Y; Shahsavari A; Lotey P; Lee RH; Liu F
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
